UPCC 35825 NCI Cervical Cancer Last Mile Initiative Self-collection for HPV testing to Improve Cervical Cancer Prevention (SHIP) Trial sub study S04

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

The NCI SHIP multi-site trial will recruit 100 individuals at Penn scheduled to undergo colposcopy to 1) evaluate self- and clinician-collected test primary HPV test accuracy by calculating clinical sensitivity and specificity for detection of CIN2+n histopathology; and 2) positive and negative percent agreement between self- and clinician-collected HPV samples.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 08 Jun 2026. Study ID: 25-1755
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator